Mr. Kiril Petrov Domuschiev was born on 18 April 1969 in the city of Sofia, Bulgaria. He completed his secondary education at the 9th Secondary Language School Alphonse de Lamartine, in Spanish class. Having completed his higher education, he was awarded a master's degree in Industrial Management and Marketing from the Technical University, Sofia.
Mr. Domuschiev is an industrialist and "true entrepreneur" with a portfolio of investments in various industries including pharmaceuticals, shipping, port management, real estate and football. He was among the first entrepreneurs to start a successful private business in Bulgaria after the change in 1990. By that time, he had founded several companies dealing with production and trade. In 2003, the activities of these companies were merged and transferred to the holding company Advance Properties OOD, of which Mr. Domuschiev shares 100% ownership together with his brother.
As President and CEO of Huvepharma Group, alongside other relevant management and/or supervisory positions in other industries including shipping, media and insurance, Mr. Domuschiev develops and implements profitable business strategies and ensures that good practices, as well as high operational standards are maintained within the group.
He is also a Chairman of the Managing Board of the Confederation of Employers and Industrialists in Bulgaria, a member of the Managing Board of the International Chamber of Commerce in Bulgaria, and on the Executive Committee to the Bulgarian Football Union.
Maria Terzieva is Chief Financial Officer of Huvepharma and responsible for the robust financial profile, planning, financial mangement and continuous support of business development, financial institution relations and business integrations. Maria supports the expansion and investments of Huvepharma and ensures the sustainable, strong financial performance and financial discipline that provides confidence to all Huvepharma stakeholders.
As CFO, Maria has built and maintains a global finance and tax shared function with lean, highly efficient and organised finance, accounting, treasury and IT teams. Her reponsibilities include defining and overseeing corporate financial policies, managing liquidity, forecasting, monitoring working capital and centralized management of the funding, budgeting and reporting functions.
Before being appointed CFO in 2014, Maria worked in different positions in Huvepharma starting in 1994 with increasing scope of responsibilities throughout her Huvepharma career. Maria is a chartered accountant and graduated from the University of National and World Economy in Sofia in Economics and Management.
Eddy Piron is Vice President of Sales and Marketing for Huvepharma and manages the global Huvepharma organization that brings Huvepharma's products and services to livestock producers and veterinarians. Eddy joined Huvepharma in 2005 sharing the vision for Huvepharma to become a leader in animal health. This was achieved by attracting highly talented experts, expanding the business via strategically placed new subsidiaries, and increasing the depth and breadth of products and services, including the addition of new species groups to support Huvepharma's global offering and growing customer base.
Before Huvepharma, Eddy worked for global animal health and nutrition companies including American Cyanamid, Fort Dodge, Roche Vitamins and Alpharma, and acquired a broad experience in many fields covering sales, marketing, regulatory affairs and business development.
Eddy graduated in 1984 as an Agricultural Engineer (magna cum laude), specialized in animal production and chemistry at the Catholic University Leuven, Belgium where he also earned a Master of Business Administration in 1988.
Eddy is also member of the board of Animal Health Europe, the federation representing the European animal health industry.
Glen is President and CEO of Huvepharma Inc USA, a position he has held since 2005. Previously, he held positions at Jones Hamilton in Walbridge, Ohio as Division Manager for Agriculture from 2003-2005, at Church & Dwight in Princeton, New Jersey as Senior Business Manager from 2001-2003, at Roche Vitamins in Parsippany, New Jersey as Area Business Director / Director of Sales from 1989-2001, at Cargill in Minneapolis, Minnesota in various roles in production, nutrition, regulatory and purchasing from 1984-1989, and at Tyson Foods in Cumming, Georgia from 1982-1984.
Glen graduated from the University of Florida in Gainesville, Florida in 1982 with a BSc in Agriculture.
Anguel is Vice President of Production for Huvepharma and CEO of Biovet. He is responsible for restructuring, management, development, investments and capacity expansion at all the production facilities of the company globally. Anguel is involved in creating, planning, implementing and integrating the strategic direction of Huvepharma.
Anguel joined Huvepharma in 2008, sharing the vision for Huvepharma to become a leader in animal health.
Before Huvepharma, Anguel worked in different positions at Advance Properties Holding and has been Executive Director of Biovet since 2000. In 2008, he was appointed Vice President of Production at Huvepharma.
Anguel graduated in 1984 from the University of National and World Economy in Sofia in Economics and Management.
Spas is Director of Business Development and his responsibilities include new projects and product development, coordination of global research and development activities and regulatory affairs. Spas initially joined the R&D department of Biovet AD, the manufacturing arm of Huvepharma, and has been involved in the process and product development behind the ever-expanding portfolio of products of the company. Spas is also a member of the Managing Board of Biovet AD and overlooks contract manufacturing projects and IP.
Spas holds an MSc in Chemical Engineering from the Pennsylvania State University and a BSc in Chemical and Biochemical Engineering from the University of Minnesota in Duluth.
Spas has authored and co-authored many scientific papers, publications and international patents for new products, formulations and processes.
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Update your browser to view this website correctly. Update my browser now